Costo-efectividad de políticas para el tamizaje de cáncer de mama en México
Salud Pública de MéxicoPublished 1 January 2009Open access
Atanacio Valencia-Mendoza, Gilberto Sánchez‐González, Sergio Bautista‐Arredondo, Gabriela Torres-Mejı́a, Stefano Bertozzi
Citations19
SJR quartileQ2
SJR score0.87
SNIP1.01
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The strategies included in the optimal method for expanding the BC program produce a cost per life-year saved of less than two times the GNP per capita and hence are cost-effective according to WHO Commission on Macroeconomics and Health criteria.
Abstract
The strategies included in the optimal method for expanding the program produce a cost per life-year saved of less than two times the GNP per capita and hence are cost-effective according to WHO Commission on Macroeconomics and Health criteria.
Keywords
MedicineEconomics, Econometrics and Finance
CA A Cancer Journal for CliniciansGlobal cancer statistics
54,961 Citations2011Ahmedin Jemal, Freddie Bray +3 more
A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination, and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake.
CA A Cancer Journal for CliniciansGlobal Cancer Statistics, 2002
18,390 Citations2005Donald Maxwell Parkin, Freddie Bray +2 more
There are striking variations in the risk of different cancers by geographic area, most of the international variation is due to exposure to known or suspected risk factors related to lifestyle or environment, and provides a clear challenge to prevention.
CA A Cancer Journal for CliniciansGlobal cancer statistics
3,421 Citations1999Donald Maxwell Parkin, Paola Pisani +1 more
New England Journal of MedicineDiagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening
1,942 Citations2005Etta D. Pisano, Constantine Gatsonis +10 more
Annals of Internal MedicineBreast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force
1,135 Citations2002Linda L. Humphrey, Mark Helfand +2 more
The goal was to critically appraise and synthesize evidence about the overall effectiveness of breast cancer screening, as well as its effectiveness among women younger than 50 years of age, and to evaluate previous meta-analyses of these trials and of screening test characteristics and studies evaluating the harms associated with false-positive test results.
International Journal of EpidemiologyGlobal trends in breast cancer incidence and mortality 1973–1997
564 Citations2005Michelle D. Althuis, Jaclyn M Dozier +3 more
Breast cancer incidence and mortality rates remain highest in developed countries compared with developing countries, as a result of differential use of screening mammograms and disparities in lifestyle and hereditary factors.
Obstetrical & Gynecological SurveyDiagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening
482 Citations2006Etta D. Pisano, Constantine Gatsonis +10 more
Obstetrical & Gynecological SurveyEffect of Screening and Adjuvant Therapy on Mortality From Breast Cancer
389 Citations2006Donald A. Berry, Kathleen A. Cronin +8 more
Seven statistical models showed that both screening mammography and treatment have helped reduce the rate of death from breast cancer in the United States.
New England Journal of MedicineMammographic Screening for Breast Cancer
376 Citations2003Suzanne W. Fletcher, Joann G. Elmore
A 44-year-old woman who is a new patient has no known current health problems and no family history of breast or ovarian cancer and recently read that mammograms may not help to prevent death from breast cancer and that “the patient should decide.”
Annals of Internal MedicineCost-Effectiveness of Extending Screening Mammography Guidelines To Include Women 40 to 49 Years of Age
251 Citations1997Peter Salzmann, Karla Kerlikowske +1 more
The cost-effectiveness of screening in women 50 years of age and older was calculated by comparing the first strategy with the second strategy and the actual delay times before the onset of benefits, and the transition probabilities were both age- and strategy-dependent.
Breast Cancer ResearchBreast cancer tumor growth estimated through mammography screening data
205 Citations2008Harald Weedon‐Fekjær, Bo Henry Lindqvist +3 more
Screening data with tumor measurements can provide population-based estimates of tumor growth and screen test sensitivity directly linked to tumor size, and there is a large variation in breast cancer tumor growth, with faster growth among younger women.
CancerA model for breast cancer screening
149 Citations1990G.J. van Oortmarssen, J. Dik F. Habbema +6 more
A model for breast cancer screening has been developed that reproduces the detection rates and the incidence of interval cancers as observed in the recent screening projects in Utrecht and Nijmegen, the Netherlands.
Intervention Cost-Effectiveness: Overview of Main Messages
149 Citations2006Ramanan Laxminarayan, Jeffrey Chow +1 more
This chapter provides broad conclusions on the economic efficiency of using these interventions to improve health, and the resulting avertable burden of disease, for 319 interventions covering nearly every disease condition considered in the volume.
Annual Review of Public HealthEVALUATING THE COST-EFFECTIVENESS OF CLINICAL AND PUBLIC HEALTH MEASURES
148 Citations1998John D. Graham, Phaedra S. Corso +3 more
Greater uniformity of analytical practice will be necessary if cost-effectiveness analysis is to become a more influential tool in debates about resource allocation.
Journal of Medical ScreeningScreening for breast cancer in England: past and future
109 Citations2006
Although some have questioned the value of screening for breast cancer, the scientific evidence demonstrates clearly that regular mammographic screening between the ages of 50 and 70 years reduces mortality from the malignancy.
American Journal of Preventive MedicineThe art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services
94 Citations2001Somnath Saha, Thomas J. Hoerger +4 more
An overview and examples of roles for using cost-effectiveness analyses to inform preventive services recommendations are provided, limitations of cost- Effectiveness data in shaping evidence-based preventive health care policies are discussed, and the methods the USPSTF is developing to assess the quality and results of Cost-Effectiveness studies are discussed.
Archives of Gynecology and ObstetricsFrequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation
69 Citations2002Christoph Schneider, Mathias K. Fehr +4 more
It is suggested that chest X-ray, liver ultrasound and bone scan can be omitted in the staging of asymptomatic patients with pT1a or pT 1b disease.
Journal of Epidemiology & Community HealthCalculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. Interval Cancer Working Group.
33 Citations1998Sue Moss, R G Blanks
The target cancer detection rates and expected interval cancer rates for the NHS Breast Screening Programme have been revised in the light of more recent data and will give a more accurate indication of the potential to meet the Health of the Nation target of a 25% reduction in breast cancer mortality by the year 2000.
CancerExamining the cost-effectiveness of cancer screening promotion
30 Citations2004M. Robyn Andersen, Nicole Urban +2 more
European Journal of Cancer CareBuilding a model to determine the cost-effectiveness of breast cancer screening in France
30 Citations2003Patrick Arveux, Suzanne Wait +1 more
The results of initial analyses suggest that the model is capable of suitably assessing the impact of breast cancer screening in terms of costs and effects, and is likely to help guide current policy discussions on the future of screening in France.
Salud Pública de MéxicoFactores pronósticos relacionados con la supervivencia del cáncer de mama
29 Citations2008Lourdes Flores‐Luna, Eduardo Salazar-Martı́nez +4 more
These results give consistency to diagnostic and therapeutic criteria for women with breast cancer who receive medical attention in Mexico, taking into consideration the charac teristics of the tumor –such as extension, clinical stage and status of the lymph nodes– before making a decision as to the initial therapy.
International Journal of Clinical Practice4. BREAST CANCER SCREENING
12 Citations2001MJ Michell
Mammographic screening reduces breast cancer mortality by 24% in women aged ≥50 years and is carried out by a specialist multidisciplinary team using the triple approach: clinical examination, imaging and, where appropriate, needle biopsy.
Asian Journal of SurgeryCorrelation Between Breast Tumour Size and Level of Axillary Lymph Node Involvement
9 Citations2005Georgette S.W. Chan, Allen Yeo +2 more
Based on size, 95.6% of patients with T1 tumours did not have level II lymph node metastases, so for these patients, level I axillary dissection is adequate, and Ultrasound-determined tumour size correlated well with final histological size.
Breast Cancer ResearchAnti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity
3 Citations2008A Stone, Helen Jones +3 more